Jun 2026 (Q3 FY26) — Aug 7, 2026
Embecta Q3 FY26 — Strong Sequential Improvement and Owen Mumford Integration
Read the full callEmbecta (EMBC) earnings
- Jun 2026
- Jun 2026 (Q3 FY26)
- Sep 2025
Embecta earnings: last reported Fri, 7 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 272 | −8.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 17.9 | −13.9 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 21.1 | −53.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$6.21 −0.96% · −$0.06
Performance −54.2% 1Y
1Y: $13.56 on 17 Oct 2025 → $6.21. High $14.64 (24 Nov 2025), low $2.9 (19 May 2026).
- Previous close
- $6.27
- 52-week range
- $2.9 – $14.64
- One year
- −55.96%
Overview
- Symbol
- EMBC
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Embecta earnings calls (EMBC)
Financials
What the filings say
Net profit, year on year: −54% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 286 | 262 | 259 | 296 | 264 | 261 | 222 | 272 |
| Operating profit | 26 | 29 | 63 | 94 | 57 | 83 | 35 | 49 |
| Operating margin | 9.2% | 11.0% | 24.3% | 31.8% | 21.4% | 31.9% | 15.8% | 17.9% |
| Other income | -4 | -1 | -0 | 5 | -1 | -0 | -3 | 3 |
| Profit before tax | -7 | -1 | 36 | 72 | 29 | 59 | 10 | 28 |
| Tax rate | 308.6% | 100.0% | 34.4% | 37.0% | 9.0% | 25.1% | 143.2% | 23.6% |
| Net profit | 15 | 0 | 24 | 46 | 26 | 44 | -4 | 21 |
| EPS ($ per share) | — | 0 | 0.40 | 0.78 | — | 0.75 | -0.07 | 0.36 |
| Line item | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|
| Equity capital | — | — | 1 | 1 | 1 | 1 |
| Reserves | — | — | -577 | -541 | -499 | -446 |
| Total liabilities | — | 194 | 1,978 | 2,036 | 2,024 | 1,742 |
| Fixed assets | — | 451 | 302 | 300 | 290 | 257 |
| Total assets | — | 788 | 1,086 | 1,214 | 1,285 | 1,091 |
| Line item | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|
| Cash from operations | 499 | 456 | 412 | 68 | 36 | 192 |
| Cash from investing | -42 | -39 | -24 | -26 | -16 | -9 |
| Cash from financing | -457 | -417 | -48 | -49 | -73 | -227 |
| Net cash flow | 0 | 0 | 331 | -4 | -52 | -46 |
| Capital expenditure | -42 | -37 | -24 | -26 | -16 | -9 |
| Free cash flow | 457 | 420 | 389 | 41 | 20 | 182 |
Insider filings
29 filings between Nov 26, 2025 and Sep 4, 2026.
Open market
decisions to buy or sellPurchases
$557.9K
4 purchases by 4 insiders
Sales
$37.0K
1 sale by 1 insider
Compensation
not trading decisions- 17
- Award — granted as compensation
- 7
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| HOMBACH ROBERT J. | $223.8K | — | Aug 12, 2026 |
| Kurdikar Devdatt | $140.9K | — | Aug 12, 2026 |
| Mann Jeffrey Z | $99.8K | — | Aug 12, 2026 |
| Elguicze Jacob | $93.4K | — | Aug 12, 2026 |
| Morris Milton Mayo | — | $37.0K | Sep 4, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Morris Milton Mayo Director | Sale | 6,293 | $37.0K |
| Aug 12, 2026 | Mann Jeffrey Z Pres, Pharm Svc&Prod Mgmt, CLO | Purchase | 20,000 | $99.8K |
| Aug 12, 2026 | Elguicze Jacob SVP and CFO | Purchase | 20,000 | $93.4K |
| Aug 12, 2026 | Kurdikar Devdatt President and CEO | Purchase | 30,000 | $140.9K |
| Aug 12, 2026 | HOMBACH ROBERT J. Director | Purchase | 45,000 | $223.8K |
| Aug 9, 2026 | Casner Jean Chief Human Resources Officer | Tax withheld | 1,480 | $6.5K |
| Jun 1, 2026 | Roth Anthony M. VP, Chief Accounting Officer | Award | 30,000 | $0 |
| Feb 11, 2026 | Pomeroy Claire Director | Award | 22,841 | $0 |
| Feb 11, 2026 | Prange Karen Director | Award | 22,841 | $0 |
| Feb 11, 2026 | Morris Milton Mayo Director | Award | 22,841 | $0 |
| Feb 11, 2026 | HOMBACH ROBERT J. Director | Award | 22,841 | $0 |
| Feb 11, 2026 | Anderson Carrie L Director | Award | 22,841 | $0 |
| Feb 11, 2026 | Reidy Christopher R Director | Award | 22,841 | $0 |
| Nov 26, 2025 | Curtis Shaun SVP, Global Manuf./Sup. Chain | Award | 11,305 | $0 |
| Nov 26, 2025 | Curtis Shaun SVP, Global Manuf./Sup. Chain | Tax withheld | 15,380 | $193.3K |
| Nov 26, 2025 | Elguicze Jacob SVP and CFO | Award | 95,466 | $0 |
| Nov 26, 2025 | Elguicze Jacob SVP and CFO | Award | 30,147 | $0 |
| Nov 26, 2025 | Elguicze Jacob SVP and CFO | Tax withheld | 24,782 | $311.5K |
| Nov 26, 2025 | Kurdikar Devdatt President and CEO | Award | 288,386 | $0 |
| Nov 26, 2025 | Kurdikar Devdatt President and CEO | Award | 103,626 | $0 |
| Nov 26, 2025 | Kurdikar Devdatt President and CEO | Tax withheld | 128,630 | $1.62M |
| Nov 26, 2025 | Mann Jeffrey Z SVP, GC, Head Corp. Dev., Secy | Award | 79,555 | $0 |
| Nov 26, 2025 | Mann Jeffrey Z SVP, GC, Head Corp. Dev., Secy | Award | 24,495 | $0 |
| Nov 26, 2025 | Mann Jeffrey Z SVP, GC, Head Corp. Dev., Secy | Tax withheld | 19,605 | $246.4K |
| Nov 26, 2025 | Casner Jean Chief Human Resources Officer | Award | 38,783 | $0 |
| Nov 26, 2025 | Casner Jean Chief Human Resources Officer | Tax withheld | 3,325 | $41.8K |
| Nov 26, 2025 | Roth Anthony M. Chief Accounting Officer | Award | 32,817 | $0 |
| Nov 26, 2025 | Roth Anthony M. Chief Accounting Officer | Tax withheld | 1,881 | $23.6K |
| Nov 26, 2025 | Curtis Shaun SVP, Global Manuf./Sup. Chain | Award | 37,789 | $0 |
| Aug 9, 2025 | Casner Jean Chief Human Resources Officer | Tax withheld | 916 | $11.2K |
| May 23, 2025 | Melcher David F Director | Purchase | 10,000 | $106.0K |
| Apr 4, 2025 | Mann Jeffrey Z SVP, GC, Head Corp. Dev., Secy | Tax withheld | 5,285 | $63.4K |
| Apr 4, 2025 | Curtis Shaun SVP, Global Manuf./Sup. Chain | Tax withheld | 3,249 | $39.0K |
| Apr 4, 2025 | Elguicze Jacob SVP and CFO | Tax withheld | 4,948 | $59.4K |
| Apr 4, 2025 | Kurdikar Devdatt President and CEO | Tax withheld | 39,592 | $475.1K |
| Feb 25, 2025 | Melcher David F Director | Purchase | 13,000 | $177.6K |
| Feb 13, 2025 | Morris Milton Mayo Director | Sale | 3,100 | $50.8K |
| Feb 12, 2025 | Pomeroy Claire Director | Award | 13,839 | $0 |
| Feb 12, 2025 | Reidy Christopher R Director | Award | 13,839 | $0 |
| Feb 12, 2025 | Prange Karen Director | Award | 13,839 | $0 |
| Feb 12, 2025 | Anderson Carrie L Director | Award | 13,839 | $0 |
| Feb 12, 2025 | Albritton David Director | Award | 13,839 | $0 |
| Feb 12, 2025 | Morris Milton Mayo Director | Award | 13,839 | $0 |
| Feb 12, 2025 | Melcher David F Director | Award | 17,450 | $0 |
| Feb 12, 2025 | HOMBACH ROBERT J. Director | Award | 13,839 | $0 |
| Dec 2, 2024 | Roth Anthony M. Chief Accounting Officer | Award | 15,762 | $0 |
| Nov 26, 2024 | Casner Jean Chief Human Resources Officer | Tax withheld | 1,281 | $24.0K |
| Nov 26, 2024 | Mann Jeffrey Z SVP, GC, Head Corp. Dev., Secy | Award | 50,803 | $0 |
| Nov 26, 2024 | Mann Jeffrey Z SVP, GC, Head Corp. Dev., Secy | Tax withheld | 8,016 | $149.9K |
| Nov 26, 2024 | Kurdikar Devdatt President and CEO | Award | 187,166 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Embecta Corp.
Free account. Everything above stays public.
Write why you follow Embecta Corp. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading